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An investigation of the chemical constituents in Artocarpus obtusus species led to the isolation of three new xanthones,
pyranocycloartobiloxanthone A (1), dihydroartoindonesianin C (2), and pyranocycloartobiloxanthone B (3). The compounds
weresubjectedtoantiproliferativeassayagainsthumanpromyelocyticleukemia(HL60),humanchronicmyeloidleukemia(K562),
and human estrogen receptor (ER+) positive breast cancer (MCF7) cell lines. Pyranocycloartobiloxanthone A (1) consistently
showed strong cytotoxic activity against the three cell lines compared to the other two with IC50 values of 0.5, 2.0 and 5.0μg/mL,
respectively. Compound (1) was also observed to exert antiproliferative activity and apoptotic promoter towards HL60 and MCF7
cell lines at respective IC50 values. The compound (1) was not toxic towards normal cell lines human nontumorigenic breast cell
line (MCF10A) and human peripheral blood mononuclear cells (PBMCs) with IC50 values of more than 30μg/mL.
1.Introduction
Tropical rain forests contain a lot of interesting pharmaco-
logically active constituents and many more are still waiting
to be discovered as they still oﬀer undoubtedly valuable and
amazing chemical entities. The World Health Organization
(WHO) reported that 11% of the 252 drugs considered as
basic and essential in this century were exclusively origin
from ﬂowering plants [1]. Many impressive modern drugs
available in the market were derived from plants source
and most of them were based on their ethnomedicinal uses.
Hence, many works on tropical plants from Malaysia are
being and have been extensively studied as well as their
biological activity. One of them is Artocarpus species. The
Artocarpus species is one of the genus in the Moraceae family
[2] and is made of about 55 species. The genus is widely
distributed throughout subtropical and tropical region of
the Indian subcontinent south of the Himalayas, Sri Lanka,
Burma, Thailand, Indo-China, Southern China, Taiwan,
Hainan, Malesia, and Melanesia [2, 3]. Some parts of the
plants are also used in traditional medicine preparations for
the treatment of various diseases such as diarrhea, fever, liver
cirrhosis, hypertension, diabetes, inﬂammation, malaria,
ulcers, wound, and for tapeworm infection [4–8]. Many
interesting biological activities and phytochemical work have
been carried out on the plants with the identiﬁcation of
various classes of interesting phenolic compounds [9–18].
Our previous works on the stem bark of A. altilis and A.
obtusus have led to the isolation of prenylated ﬂavonoids and
xanthones [19, 20].
In preliminary screening for cytotoxic, antioxidant and
antimicrobial activity of thirteen Malaysian Artocarpus
species has resulted in the potential of a few species for
further examination in particular A. obtusus Jarret [13].
The plant is endemic to Sarawak, and, in continuation of
our investigation on Malaysian plants, we now described
the antiproliferative activity of three new xanthones isolated
from the stem bark of A. obtusus. The cytotoxic activity2 Journal of Biomedicine and Biotechnology
was tested using MTT assay against human promyelocytic
leukemia (HL60), human chronic myeloid leukemia (K562),
and human estrogen receptor (ER+) positive breast cancer
(MCF7).Themostactivexanthonewasfurthertestedagainst
mouse embryo ﬁbroblast (3T3), human cervical cancer
(HeLa), human estrogen receptor (ER−) negative (MDA-
MB 231), human colon cancer (HT29) and human hepato-
carcinoma (HepG2), human nontumorigenic breast cell line
(MCF10A), and human peripheral blood mononuclear cells
(PBMCs). The potential compound was also analyzed for
its antiproliferative activity and eﬀect on cell morphology of
HL60 and MCF7 cell lines at selected concentrations using
BrdU and acridine orange and propium iodide staining,
respectively. Currently, there is no recognized ethnomedic-
inal data and reported biological activity for A. obtusus;t h u s ,
this is the ﬁrst report on antiproliferative activity studies of
the isolated xanthones from the plant as well as the isolation
and structural elucidation of compound (3).
2.MaterialsandMethods
2.1. General Experimental Procedures. All melting points
(m.p.) were determined using a hot stage melting point
apparatusmodelLeicaGALENIIIequippedwithmicroscope
a n da r eu n c o r r e c t e d .U Va n dI Rs p e c t r aw e r em e a s u r e dw i t h
Shimadzu UV 2100 and Perkin Elmer FTIR (model 1725X)
spectrophotometers, respectively. The 1H-NMR and 13C-
NMR spectra were obtained with JEOL ECA-400 spectrom-
eter operating at 400 and 100MHz with tetramethylsilane
(TMS) as an internal standard, respectively. The MS were
obtained with Shimadzu GCMS-QP5050 spectrometer with
Direct Induction Probe (DIP) using ionization induced
by electron impact at 70eV. Column chromatography was
carried out using Merck Si gel 60 No. 1.07734, Darmstadt,
Germany. Analytical thin layer chromatography (TLC) was
performed on commercially available Merck TLC plastic
sheet precoated Kieselgel 60 F254, 0.2mm thickness, and the
chromatotron plates were coated with Kieselgel 60 F254 and
scrapped to 1mm thickness.
2.2. Plant Material. Sample of the air-dried stem bark of
Artocarpus obtusus wascollectedfromSarawakin2004,iden-
tiﬁed by Dr. Rusea Go, and a voucher specimen (S94402) has
been deposited at the Herbarium, Department of Biology,
Faculty of Science, Universiti Putra Malaysia.
2.3. Preparation of Plant Extracts and Isolation Procedure.
The dried ground stem bark (640g) of Artocarpus obtusus
was sequentially extracted with n-hexane, chloroform and
methanol at room temperature. The extracts were con-
centrated in vacuo to give 3g (0.47%), 9g (1.4%), and
6 g( 0 . 9 4 % )o fd a r kv i s c o u sn-hexane, chloroform, and
methanol extracts, respectively. The chromatographic iso-
lation procedure to obtain pyranocycloartobiloxanthone A
(1) and dihydroartoindonesianin C (2) from the chloro-
form extract has been described previously [20]. Similarly,
the dark viscous methanol extract (6g) was separated by
gravity column chromatography and eluted with mixture
of solvents of increasing polarity consisting of n-hexane,
n-hexane/CHCl3, CHCl3, CHCl3/MeOH, and MeOH to
aﬀord 45 fractions of 200mL each. Another batch of
compounds (1)a n d( 2) were obtained from fractions 11–
19 after a series of silica gel column chromatographic
separation. Fractions 26–32 were combined and applied
on column chromatography of Sephadex LH20 and eluted
with methanol to give 45 fractions of 100mL each. The
combined fractions 18–28 were further chromatographed
by a series of column chromatography using silica gel and
eluted with solvent mixture of n-hexane, n-hexane/CHCl3,
CHCl3, CHCl3/MeOH, and MeOH to aﬀord yellow solid
(25.0mg). The solid was recrystallized with chloroform as
needle-shaped pyranocycloartobiloxanthone B (3) with Rf
value of 0.5 (EtOAc:CHCl3;,4:1) and m.p. 218–220◦C.
2.4. Spectral Data. Pyranocycloartobiloxanthone A (1);
C25H22O8, yellow needle-shaped crystals, and m.p. 288–
290◦C. The spectral data of the compound are identical to
literature values [20].
Dihydroartoindonesianin C (2); C25H24O6, yellow
needle-shaped crystals, and m.p. 210–212◦C. The spectral
data of the compound are identical to literature values [20].
Pyranocycloartobiloxanthone B (3), C25H22O8, yellow
needle-shaped crystal with m.p. 218–220◦C; UV (Acetone)
λmax nm (log ε): 381 (0.57), 256 (4.00), and 229 (0.32);
IR νmax cm−1 (KBr): 3390 (OH), 1642 (C = O), 1474,
1270, 1160, 982; EIMS m/z (% intensity): 450 (26.50), 436
(28.00), 435 (100), 377 (60.00), 378 (18.00), 349 (6.00), 331
(4.50), 188 (14.00), and 166 (6.00); HREIMS m/z 450.1329
[M]+ (calcd for C25H22O8, 450.1314). 1H-NMR (400MHz,
Acetone-d6): 1.19 (3H, d, J = 6.4Hz, H-15), 1.45 (6H, s, H-
19, H-20), 1.91 (1H, m, H-11), 2.25 (1H, dd, J = 15.6, 7.7Hz,
H-13), 2.76 (1H, m, H-12), 3.32 (1H, m, H-11), 5.47 (1H, s,
H-14),5.65(1H,d,J =10.0Hz,H-17),6.12(1H,s,H-6),6.49
(1H, s, H-3 ), 6.93 (1H, d, J = 10.0Hz, H-16), 7.96 (1H, brs,
OH-13), 8.44 (1H, brs, OH-2 ), 8.84 (1H, brs, OH-4 ), 13.37
(1H, brs, OH-5); 13C-NMR (100MHz Acetone-d6): 16.5 (C-
15), 24.2 (C-11), 29.8 (C-19), 30.0 (C-20), 33.9 (C-12), 38.8
(C-13), 80.2 (C-18), 96.5 (C-14), 101.3 (C-6), 103.6 (C-3),
105.5 (C-3 ), 105.8 (C-10), 107.1 (C-8), 114.3 (C-1 ), 117.6
(C-16), 127.3 (C-6 ), 129.4 (C-17), 135.0 (C-5 ), 153.2 (C-
4 ),153.6(C-2 ),153.8(C-5),161.0(C-9),163.1(C-2),164.1
(C-7), and 182.3 (C-4) (Figure 1).
2.5. In Vitro Assay for Antiproliferative Activity
2.5.1. Cell Lines. The cancerous and noncancerous cell lines
(suspension and anchorage-dependent cells) were obtained
from the American Type Culture Collection (ATCC) and
the RIKEN Cell Bank (RCB). The cancerous cell lines used
were HL-60 (human acute promyelocytic leukemia) (RCB),
K562 (human chronic myeloid leukemia) (ATCC), MCF7
(human estrogen receptor (ER+) positive breast cancer)
(ATCC), HeLa (human cervical cancer) (ATCC), HepG2
(human hepatocarcinoma) (ATCC), HT29 (human colon
cancer) (RCI), and MDA-MB 231 (human estrogen receptor
(ER−) negative) (ATCC). The noncancerous cell line and
normal cells were 3T3 (Mouse embryo ﬁbroblast) (ATCC),Journal of Biomedicine and Biotechnology 3
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Figure 1: The chemical structure of the three isolated compounds tested for antiproliferative activity, pyranocycloartobiloxanthone A (1),
dihydroartoindonesianin C (2), and pyranocycloartobiloxanthone B (3).
MCF10A (human nontumorigenic breast cell line) (ATCC)
and PBMC (human peripheral blood mononuclear cells).
PBMCswereobtained fromone oftheauthorsherself.Blood
(10–12mL) was taken from the donor by using the 25mL
syringe. The blood sample was diluted with same volume
of PBS. The diluted blood sample was carefully layered on
Ficoll-Paque Plus (Amersham Biosciences, USA) the ratio
of 2:1. The mixture was centrifuged at 1500× gf o r4 0
minutes at 18–20◦C. The undisturbed lymphocyte layer was
carefully transferred into centrifuge tube. The lymphocyte
was washed and spun down three times by adding 10mL
sterile PBS and to get the pellet and resuspended in RPMI
1640 (Sigma, USA) with 100IU/mL of penicillin, 100μg/mL
of streptomycin (Flowlab, Australia), and 10% v/v Fetal
Bovine Serum (FBS) (PAA, Austria). Cell counting was
performed to determine the PBMC number in equal volume
of trypan blue.
2.5.2. Cytotoxic Analysis by the MTT Assay. The colorimetric
assay was performed on the isolated compounds using a
modiﬁed microculture tetrazolium salt (MTT) assay (Sigma,
USA) [21]. Varying concentrations of 0.46, 0.93, 1.87, 3.75,
7.5, 15, and 30μg/mL of pyranocycloartobiloxanthone A (1),
dihydroartoindonesianin C (2), and pyranocycloartobilox-
anthone B (3) were prepared from the substock solutions
by serial dilution in RPMI 1640 to give a volume of 100μL
in each microtitre plate well (96-ﬂat bottom microwell
plates). Each well was then added with 100μL of cell lines
in complete growth media (RPMI 1640) 5 × 105 cells/mL.
Untreated cells were used as control and included for each
sample. The assay for each concentration of compounds was
performedintriplicate.Thecultureplateswereincubatedfor
72 hour at 37◦C in a humidiﬁed (90%) incubator with 5%
CO2. After incubation, the fractions of surviving cells were
determined relative to the untreated cell population using
the colorimetric MTT assay. In this method, the viabilities
of the cells were determined by measuring the amount
of blue formazan crystals formed after 20mL of freshly
prepared MTT solution (5mg in 1mL PBS) was added to
each well followed by four hours of incubation at 37◦C.
Then, 170μL of the remaining supernatant was removed,
100μL of DMSO was added to each well, and the mixture
was stirred thoroughly to dissolve the blue crystal formazan.
The plate was then incubated for 30 minutes to ensure
that all the crystals were dissolved. Finally, the absorbance
(OD) of each well at 570nm of wavelength was read
using the microplate reader (ELISA reader, EL340 Biokinetic
Reader, Bio-Tek Instrumentation). Doxorubicin was used as
a positive control. A graph was plotted for the percentage
of cell viability against concentration of the extract, and the
cytoxicity index used was IC50, the concentration that yields
50% inhibition of the cell compared with untreated control.
T h ep e r c e n t a g eo fc e l lv i a b i l i t yw a sd e t e r m i n e da sf o l l o w s :
%V i a b i l i t y =
ODsample
ODcontrol
× 100%. (1)
2.6. Cell Proliferation ELISA BrdU (5-bromo-2 -deoxy-
uridine) Assay (Colorimetric). This assay was conducted
to determine the antiproliferative eﬀects of the tested
compound. In this assay, three diﬀerent concentrations of4 Journal of Biomedicine and Biotechnology
Table 1: 1H-NMR (400MHz) and 13C-NMR (100MHz) spectral data of pyranocycloartobiloxanthone B (3) and pyranocycloartobiloxan-
thone A (1).
H/C (3) In acetone-d6 (1)In DMSO [13]
δH (in ppm, J in Hz) δC (in ppm) HMBC δH (in ppm) δC (in ppm)
2 — 163.1 — — 160.7
3 — 103.6 — — 100.8
4 — 182.3 — — 179.1
5 — 153.8 — — 151.2
6 6.12 (1H, s) 101.3 C-5, 7, 8 6.17 98.7
7 — 164.1 — — 160.7
8 — 107.1 — — 104.3
9 — 161.0 — — 157.9
10 — 105.8 — — 103.6
11 1.91 (1H, m) 24.2 C-3, 6  1.88 21.5
3.32 (1H, m) C - 3 ,4 ,C - 1 2 3 . 3 2
12 2.76 (1H, m) 33.9 C-13, 1 ,5  ,6   2.55 31.2
13 2.25 (1H, dd, J = 15.6, 7.7) 38.8 C-12, 14, 6  1.82 35.7
14 5.47 (1H, s) 96.5 C-13, 15 5.32 93.1
15 1.19 (3H, d, J = 6.4, CH3) 16.5 C-12, 13, 14 1.08 14.6
16 6.93 (1H, d, J = 10.0) 117.6 C-7, 9, 18 6.86 114.8
17 5.65 (1H, d, J = 10.0) 129.4 C-16, 18, 19 5.74 127.3
18 — 80.2 — — 78.0
19 1.45 (3H, s,C H 3) 29.8 C-17, 18 1.44 27.7
20 1.45 (3H, s,C H 3) 30.0 C-17, 18 1.42 27.9
1  — 114.3 — — 111.0
2  — 153.6 — — 151.2
3  6.49 (1H, s) 105.5 C-2 ,4  ,5   6.43 103.1
4  — 153.2 — — 151.1
5  — 135.0 — — 132.5
6  — 127.3 — — 124.6
OH-5 13.37 (1H, brs) — C-6, 7, 10 13.36 —
OH-13 7.96 (1H, brs)——— —
OH-14 — — — 6.93 —
OH-2  8.44 (1H, brs)—— 9 . 9 1 —
OH-4  8.84 (1H, brs)— C - 3   9.81 —
compound or test sample were prepared together with
control. The concentration chosen were 1μg/mL, the IC50
concentration, and 20μg/mL. Two types of cells were
selected: HL-60 (suspension) and MCF7 (adherent) cells,
since they gave the most signiﬁcant results for the cytotoxic
activity. The procedures are according to the instruction
manual from Roche. Each sample was assayed in tripli-
cate, and control samples include a blank (no cells) and
background (without BrdU). The cells were treated by
pyranocycloartobiloxanthone A (1) for 24, 48, and 72 hours.
Thecellswereculturedtogetherwithvariousdilutions oftest
substance (tested compound) in 96-well MP ﬂat bottom in a
ﬁnal volume of 100μL/well, and 10μL BrdU label (diluted by
1/2000 in media) was added to each well and incubated for
24 hour at 37◦C. BrdU label was then replaced with 200μL
of ﬁx/denaturing solution for 30min at room temperature
(25◦C) and removed by inverting the plate. The anti-BrdU-
POD working solution (100μL/well) (diluted by 1/100 in
dilution buﬀer) was added and incubated for one hour at
room temperature. The cells were washed three times with
wash buﬀer and once with dH2O. Then, removed dH2O
and 100μL of substrate solution was added to each well and
incubated for 15min at room temperature in the dark. The
stop solution (100μL/well) was added, and the absorbance
was measured using ELISA reader at 450nm, (reference
wavelength 690). The activity was observed by the optical
density (OD) of the absorbance at 450nm, and graphs were
plotted from the optical density obtained against time of
e x p o s u r ef o re a c hc e l ll i n e s .
2.7. Acridine Orange (AO) and Propodium Iodide (PI)
Staining. Cell suspensions were mixed with an equal volume
of staining solution (1:1) containing 10μg/mL acridine
orange and 10μg/mL propium iodide (dissolved in PBS)
and observed under ﬂuorescence microscope within 30
minutes. The viable (green intact cells), apoptotic (greenJournal of Biomedicine and Biotechnology 5
Table 2: The IC50 values of isolated compounds towards various
cell lines.
Cell line IC50 (μg/mL)
(1)( 2)( 3) Doxorubicin
HL60 2 ±0.72 6 ±0.81 7 ±0.80 .2 ±0.03
K562 0.5 ±0.05 >30 >30 nt
MCF7 5 ±1.22 7 ±1.92 3 ±1.30 .2 ±0.06
HeLa 8 ±3.3n t n t n t
MDA-MB 231 12 ±1.1n t n t n t
HT29 14 ±1.5n t n t n t
HepG2 20 ±2.0n t n t n t
3T3 7 ±1.6n t n t n t
MCF10 >30 nt nt nt
PBMC >30 nt nt >30
Note: (nt)-not tested, (1)-pyranocycloartobiloxanthone A, (2)-dihydroar-
toindonesianin C, and (3)-pyranocycloartobiloxanthone B. Data represent
mean ± SD of triplicate determinations from three independent experi-
ments.
shrinking cells with condensed of fragmented nucleus), and
necrotic(redcells)werethemorphologicalchangesthatwere
examined under ﬂuorescence microscope.
3. Results andDiscussion
Based on the biological screening test results on 39 extracts
from thirteen species of Artocarpus species, the three extracts
of Artocarpus obtusus exhibited excellent cytotoxic activity
against HL60 cells with IC50 v a l u e sf r o m1 . 4t o8 . 4 μg/mL
[13]. However, only chloroform extract of A. obtusus
exhibited cytotoxic activity towards MCF7 cells with IC50
values 22.60μg/mL, while the other extracts were inactive
towards thecell. Theseextractswerefurtherphytochemically
investigatedwiththeisolationandidentiﬁcationofthreenew
xanthones, pyranocycloartobiloxanthone A (1), dihydroar-
toindonesianin C (2), and pyranocycloartobiloxanthone B
(3). The structural elucidation of two of xanthones, (1)a n d
(2) isolated from the chloroform extract, has already been
published recently [20], and the structure determination
of the third xanthone (3) is included in this presentation.
After chromatographic separation of the methanol extract,
pyranocycloartobiloxanthone B (3) was obtained as yellow
needle-shaped crystals with m.p. 218–220◦C. The UV spec-
trum exhibited absorption bands at λmax 381, 256, and
229nm for a typical xanthone skeleton. Broad and strong
absorptions were noted at 3390 and 1642cm−1 in the IR
spectrum due to the presence of hydroxyl and carbonyl
functionalities.TheEIMSgavemolecularionpeakatm/z450
which is consistent with molecular formula C25H22O8.T h e
high-resolution EIMS exhibited molecular ion peak at m/z
450.1329 (calculated C25H22O8 for m/z 450.1314). The 1H-
NMR displayed characteristic signals for chelated phenolic
hydroxyl group at δ 13.37 and a 2,2-dimethylchromene ring
substituent with the observation of a pair of oleﬁnic protons
atδ 6.93and5.65withidenticalcouplingconstantof10.0Hz
and a sharp singlet of two overlapped methyl groups at δ
1.45.Thearomaticregionalsorevealedtheoccurrenceoftwo
HO
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OH
OH
O O
O
O
CH3
H
H
H
H
H
H H
H
Figure 2: Selected HMBC of pyranocycloartobiloxanthone B (3).
singlets at δ 6.12 (H-6) and 6.49 (H-3 ), and another high
ﬁeld resonance at δ 1.19 assigned to methyl group at C-15.
The two broad chemical shifts noted at δ 8.44 and 8.84 were
due to the hydroxyl groups attached to aromatic ring at C-2 
and C-4 .
The 13C-NMR and DEPT spectra indicated the existence
of twenty-ﬁve signals contributed by fourteen quaternary
carbons including a conjugated carbonyl (δ 182.3), seven
methine, one methylene (δ 24.2), and three methyl (δ 16.5,
29.8,and30.0)carbonatoms.These 1H-NMRand 13C-NMR
spectral data were quite similar to pyranocycloartobiloxan-
thone A (1) but with some obvious diﬀerences especially
the location of one the hydroxyl groups at C-14 now shifted
to C-13 which occurred at δ 38.8. The methyl group at C-
13 shifted to C-14 and the chemical shift of this carbon
now shifted upﬁeld at δ 96.5 (Table 1). On the basis of
HMQCandHMBCspectralanalysis,thechemicalshiftswere
fully assigned, and the positions of the substituents on the
pyran and aromatic rings were determined. The 2J and 3J
correlations of both protons at H-6 to -5, C-7, and C-8, H-
3  to C-2 ,C - 4  , and C-5  conﬁrmed the position of each
respective aromatic protons. The two-bond and three-bond
correlations were also used to locate the positions of both
methyl and hydroxyl groups in the pyran ring (Figure 2).
In (1), the methyl protons at C-15 exhibited correlations
with C-12, -13, and -14 [20]. However, the methyl protons
only showed correlations to C-13 and 14 in compound (3)
which supported the attachment of this methyl group at C-
14. Similarly, the methine proton at C-12 do not indicate any
correlationtothemethylgroup.Basedonthesespectraldata,
the structure of this new xanthone was assigned and given
trivial name pyranocycloartobiloxanthone B (3).
Byusingthreetumorcelllines(HL60,K562,andMCF7),
a comparison was made between the three new xanthones
to establish which has greater cytotoxicity. The cytotoxic
activity was assayed at various concentrations, expressed
in IC50 values (μg/mL) under continuous exposure for 72
hours, and is summarized in Table 2. The estimated IC50
values were obtained from the plotted graphs of percentage
cell viability (%) against various concentrations of the com-
pounds (μg/mL) (Figures 3 and 4). The study showed pyra-
nocycloartobiloxanthone A (1) exhibited potent cytotoxic
activity against the three cell lines with IC50 ranged from6 Journal of Biomedicine and Biotechnology
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Figure 3: Percentage viability of HL60 cells treated with diﬀerent
concentration of pyranocycloartobiloxanthone A (1) (PA), dihy-
droartoindonesianinC(2)(DC),andpyranocycloartobiloxanthone
B (3)(PB) measured after 72 hours using MTT assay.
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Figure 4: Percentage viability of MCF7 cells treated with diﬀerent
concentration of pyranocycloartobiloxanthone A (1) (PA), dihy-
droartoindonesianinC(2)(DC),andpyranocycloartobiloxanthone
B( 3) (PB) measured after 72 hours using MTT assay.
0.5–5.0μg/mLincomparisonwiththeothertwocompounds
which only displayed moderate cytotoxic activities towards
HL60 and MCF7 cell lines. Both compounds also failed to
inhibit the growth of K562 cell line. In order to establish the
potential of pyranocycloartobiloxanthone A (1) as a good
cytotoxic agent, the compound was further tested against
seven other cell lines (HeLa, MDA-MB 231, HT29, HepG2,
3T3, MCF10A, and PBMC). Due to insuﬃcient amount of
samples, compounds (2)a n d(3) were not further tested
against these cell lines. The IC50 values on the sensitivity
of MDA-MB 231, HT29, and HepG2 cell lines towards
pyranocycloartobiloxanthone A (1) were obtained at 12.0,
14.0, and 20.0μg/mL, respectively. However, the compound
was not toxic towards normal cell lines, MCF10A and PBMC
except for 3T3. The toxic eﬀect of the compound displayed
against 3T3 may be due to genetic changes occurred in the
cell, or the compound was toxic to mouse cells. However
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Figure 5: Eﬀect of pyranocycloartobiloxanthone A (1)o nt h e
proliferation of HL60 cells in vitro. After treatment with 1μg/mL,
2μg/mL (IC50 based on MTT results) and 20μg/mL for 24, 48, and
72hourscellular proliferationofHL60cellswas assayedusingBrdU
incorporation ELISA.
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Figure 6: Eﬀect of pyranocycloartobiloxanthone A (1)o nt h e
proliferation of MCF7 cells in vitro. After treatment with 1μg/mL,
5μg/mL (IC50 based on MTT results) and 20μg/mL for 24, 48,
and 72 hours cellular proliferation of MCF7 cells was assayed using
BrdU incorporation ELISA.
further tests are needed to be carried out to underline the
eﬀect. The sensitivity of the compound towards the cell lines
were comparable to doxorubicin used in the test.
The investigation on the potential cell proliferation
inhibition activity of pyranocycloartobiloxanthone A (1)
on HL60 and MCF7 cells was conducted due to their
signiﬁcant sensitivity (based from MTT assay) towards
the compound. The results showed that at high and IC50
concentrations of pyranocycloartobiloxanthone A (1) on
treated HL60 and MCF7 populations, the degree of cell
killing or antiproliferative activity was signiﬁcant, denoted
by slight declined of OD value of absorbance over prolonged
exposuresincomparisontotheuntreatedcontrolpopulation
(Figures 5 and 6) .T h eO Dv a l u e sf o rt h eI C 50− treated HL60
populations were 0.8, 0.78, and 0.66 for 24, 48, and 72 hours,
respectively. On the other hand, OD values of the untreatedJournal of Biomedicine and Biotechnology 7
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Figure 7: Morphology features of HL60 cells incubated with pyranocycloartobiloxanthone A (1) after being stained with acridine orange
and propidium iodide were observed under ﬂuorescence microscope (magniﬁcation 200x) (a) untreated HL60 cells (b) treated with
pyranocycloartobiloxanthone A (1)a t2μg/mL (IC50 value), after 72 hours. Note: V: viable, A: apoptosis, and N: necrosis.
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Figure 8: Morphology features of MCF7 cells incubated with pyranocycloartobiloxanthone A (1) were observed under ﬂuorescence
microscope (magniﬁcation 200x) (a) untreated MCF7cells (b) treated with pyranocycloartobiloxanthone A (1)a t5μg/mL (IC50 value),
after 72 hours. Note: V: viable, A: apoptosis, and N: necrosis.
HL60 populations were 1.34, 1.26, and 1.65 for 24, 48, and
72 hours, respectively. Therefore, the exposure of HL60 cells
to pyranocycloartobiloxanthone A (1) at IC50 concentration
for 24, 48, and 72 hours resulted in a reduction from 60
to 40% of BrdU incorporation in comparison with the
untreatedpopulation.AslightdeclineofODvaluesforIC50−
treated MCF7 populations was observed from 0.89, 0.75, and
0.66 at 24, 48, and 72 hours, respectively. In the untreated
populations, the OD values were 1.44, 2.08, and 2.88 for 24,
48, and 72 hours, respectively. The exposure has resulted
in reduction from 61.8 to 23% of BrdU incorporation in
comparison with untreated population. As indicated above,
the data exhibited the exposure time remarkably inﬂuenced
on the growth of HL60 and MCF7 cells in the ELISA BrdU
assay. Both cells experienced a noteworthy decline in cell
proliferations compared to the control populations at any
concentration as the time of exposure increased. The time
coursestudiesindicatedthatpyranocycloartobiloxanthoneA
(1) was sensitive to HL60 and MCF7 cells by inhibiting the
cell proliferation. Hence, the inhibition of cellular prolifera-
tion for both cells treated with pyranocycloartobiloxanthone
A (1) was consistent with the decline in cell viability from
the MTT assay evaluation. Hence, the reduction of OD or
viability which is observed in MTT assay may reﬂect cell
death and/or reduced rate of proliferation.
In contrast, by utilizing AO/PI staining, we were able
to determine the percentage and mode of cell death by
uptake of diﬀerent ﬂuorescence dyes and morphological
changes of individual cell in the treatment group. In the
morphological study, pyranocycloartobiloxanthone A (1)
was chosen for further study as it has shown signiﬁcant
activity against selected cancer cell lines compared to other
isolated compounds. The cells, HL60 and MCF7, were
treated with respective IC50 values, 2μg/mL, and 5μg/mL
of pyranocycloartobiloxanthone A (1) after 72 hours of
incubation. The cells were observed under ﬂuorescence
microscopepriorAOPIstaining.Bothapoptoticandnecrotic
features were observed in HL60 and MCF7 cells population
after treatment with pyranocycloartobiloxanthone A (1) at
their respective IC50 dose (Figures 7 and 8). However, the
compound seemed to kill both cells in apoptotic manner
at IC50 dose, whereby upon swelling of the cells, little buds8 Journal of Biomedicine and Biotechnology
started to appear around the cells. The buds disintegrate
from the mother cell to form apoptotic bodies while the
mother cell will shrunk. Cell rupture was observed after the
prolongedexposure(72hours)andresultedintheformation
of cellular debris. There are several genes involved with
apoptosis in mammalian cells, and the apoptotic response is
determined by a balance between antiapoptotic genes (Bcl-2
and p53) and proapoptotic genes (C-myc and Bax proteins)
[22]. In cancer, there is a lack of equilibrium between the
rate of cell division and cell death (apoptosis), therefore, any
compounds or agents that are able to promote or suppress
apoptosis are potential to be developed as anticancer drugs.
The current study showed that the compounds were
sensitive or toxic towards the selected cell lines, and
the response of each cell lines towards the compounds
was diﬀerent. Diﬀerential antiproliferative activity of the
compounds indicated that the cells may have diﬀerent
particular molecular site or receptor for selected compounds
to interact, which may inﬂuence the response of the activity
[22]. Pyranocycloartobiloxanthone A (1) exhibited poor
toxicity with high IC50 values (>30μg/mL) against PBMC
and MCF10A cells which is a good indication that normal
human cell lines may be resistant to the compound. The
suggested eﬀective doses for a 50% inhibition in cell viability
forplantextractsandpurecompoundtobeconsideredactive
according to National Cancer Institute (NCI) guidelines
should be less than 20 and 4μg/mL, respectively [23]. It
is interesting to note that, pyranocycloartobiloxanthone A
(1), at low concentration, exhibited its antiproliferative eﬀect
against most of the selected cancer cell lines. On the other
hand, the other two compounds, dihydroartoindonesianin
C (2) and pyranocycloartobiloxanthone B (3) require high
concentrations to exert their antiproliferative eﬀect towards
HL60, K562, and MCF7 cells. This ﬁnding is possibly
due to the presence of active sites in the structure of the
compounds, whereby the presence of the resorcinol moiety
in ring B and isoprenyl substituent at C-3 of the ﬂavones
skeleton may contribute to the interesting activity [9, 24].
Therefore, by having the above two features together in
the chemical structure of pyranocycloartobiloxanthone A
(1), they have substantiated the remarkable antiproliferative
activity displayed. Surprisingly, in spite of having both active
features together and also an isomer to compound (1),
pyranocycloartobiloxanthone B (3) displayed lower antipro-
liferative activity towards the target cell lines. This may be
due to the migration of the hydroxyl group from C-14 to C-
13 and methyl group in the opposite direction in compound
(3). As for dihydroartoindonesianin C (2), position C-3
is also substituted with isoprenyl group but without the
resorcinolskeletoninthechemicalstructure,andthismaybe
caused much lower antiproliferative eﬀect than compound
(1). These ﬁndings indicated that both resorcinol moiety
in ring B and isoprenyl substituent at C-3 position must
be the most important features for revealing the potent
activity. Thus, the continuing phytochemical investigation of
Malaysian Artocarpus species cannot only identify new lead
compounds as anticancer agents but also provide a pool of
chemicals for future biological target studies.
4. Conclusion
The extracts of A. obtusus were found to exhibit good
cytotoxicandpotentialantiproliferativeactivityagainstsome
cell lines and further isolation work on the extracts resulted
in the isolate ion of three new xanthones. The structures of
the compounds were established by spectroscopic method
andcomparisonwithliteraturevalues.Oneofthexanthones,
pyranocycloartobiloxanthone A (1), showed potent antipro-
liferative activity towards various cell lines and inactive when
tested on normal cell lines. The compound (1) was able to
induce apoptosis against HL60 and MCF7 cell lines at its
respective IC50 values.
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